Alternative scheduling of pulsatile, high dose sunitinib efficiently suppresses tumor growth

Increased exposure to multitargeted kinase inhibitor sunitinib is associated with improved outcome, emphasizing the importance of maintaining adequate dosing and drug levels. The currently approved schedule (5...

from Cancer via ola Kala on Inoreader http://ift.tt/2c93B9C
via IFTTT